Advertise here
Advertise here
Headlines

Data support pembrolizumab regimen as ‘new standard’ for advanced cervical cancer

Pembrolizumab plus chemoradiotherapy has shown to significantly improve overall survival for women with high-risk locally advanced cervical cancer. The FDA approved this regimen based on progression-free survival data from a phase 3 trial. Results presented at the ESMO Congress demonstrated a higher 36-month OS rate with pembrolizumab compared to a placebo. The regimen showed consistent…

Read More

Bristol immunotherapy hits in lung cancer, advancing to Phase 3

A Phase 2 trial in Barcelona, Spain, showed that adding a second immunotherapy from Bristol Myers Squibb to an existing checkpoint inhibitor and chemotherapy improved responses for certain patients with lung cancer. The trial tested Opdualag, a combination of Bristol’s Opdivo and relatlimab, targeting a checkpoint called LAG-3. While Opdualag is approved for advanced melanoma,…

Read More

Need medicine in hospital? Study finds how often IT flaws lead to the wrong drug or dose

A study identified that technology-related errors are common when prescribing medications in hospitals, with one in three errors being attributed to electronic systems. High-risk medications like oxycodone and insulin were often associated with these errors. The study also found that technology-related errors persisted over time, even years after implementing electronic systems. Examples of system design…

Read More

Doublet Immunotherapy Disappoints in Gastric Cancer Study

A study presented at the ESMO Congress in 2024 found that combining standard FOLFOX chemotherapy with doublet immunotherapy did not improve progression-free survival in patients with HER2-negative gastric or gastroesophageal junction adenocarcinoma. The study, known as AIO-STO-0417 (MOONLIGHT), aimed to explore whether adding doublet immunotherapy to chemotherapy would provide additional benefits. Results showed that the…

Read More

Best Foot Braces For Comfort And Support: A Comprehensive Guide

Foot braces play a crucial role in managing foot pain, aiding in recovery, and preventing further injuries. They offer support for various conditions like sprains, strains, and plantar fasciitis, catering to athletes, injury recoveries, and daily activities. Understanding the types of foot braces available, such as ankle braces, compression foot sleeves, plantar fasciitis night splints,…

Read More

Improved Access to CGM Data Empowers Providers and Patients to More Effectively Partner on  Diabetes Management

Continuous Glucose Monitoring (CGM) technology has revolutionized diabetes management by providing real-time, accurate data that allows for personalized insights and timely interventions. By sharing CGM data with healthcare providers, patients can receive targeted recommendations to improve their glycemic control and outcomes. CGM reduces the need for frequent in-person visits, optimizing resource allocation and cost savings…

Read More

Won’t anybody think of the doctors?

The author discusses the ongoing under-investment in healthcare in Ireland, exemplified by the Children’s Hospital debacle. The Irish Medical Organisation (IMO) recently called for the €13 billion Apple tax windfall to be exclusively invested in the healthcare sector. The author questions whether this investment in healthcare would provide the best value compared to other areas…

Read More

Bergen New Bridge Medical Center, NeuroFlow partner to measure patient progress

Bergen New Bridge Medical Center in New Jersey is partnering with NeuroFlow to assess patient population risk and improve behavioral health care. The alliance aims to integrate workflow tools to identify and prioritize mental health needs and enhance resource allocation. The focus is on tracking patient progress, especially among the almost 70% Medicaid population. NeuroFlow’s…

Read More

Understanding, classifying EDOF lenses and indications key for patient selection

At the European Society of Cataract and Refractive Surgeons meeting, Dr. Jorge L. Alió discussed extended depth of focus (EDOF) lenses, clarifying the differences between them and their specific indications. He emphasized the importance of understanding the optical design and defocus curve when selecting a lens, and suggested looking at independent clinical studies for guidance….

Read More

NIH funds new research to combat emerging viruses

Albert Einstein College of Medicine has received a grant from the NIAID for a project called PROVIDENT to develop vaccines and therapies against emerging viruses. Led by Dr. Kartik Chandran, the project aims to focus on virus families to quickly create countermeasures during pandemics, learning from previous outbreaks like COVID-19. The grant will fund research…

Read More

No DFS Benefit With Adjuvant Durvalumab in Early NSCLC

In a phase 3 trial, adjuvant durvalumab did not significantly improve disease-free survival in early-stage non-small cell lung cancer following resection compared to placebo. The study included over 1,200 patients with no EGFR or ALK mutations, and results were presented at the European Society for Medical Oncology Congress. The findings contrast with prior trials showing…

Read More

Charlie Health Partners with Cartwheel to Address the Student Mental Health Crisis

Charlie Health has partnered with Cartwheel to provide mental health support to over 400,000 students in more than 100 school districts. Charlie Health offers virtual mental health treatment for adolescents and adults, while Cartwheel partners with K-12 school districts to provide virtual therapy and psychiatry. Through this partnership, students in Cartwheel’s network can access higher…

Read More

RCSI opens €32 million Education and Research Centre

RCSI President Deborah McNamara opened a new €32 million Education and Research Centre at Connolly Hospital, joining the Smurfit Education and Research Centre at Beaumont Hospital as RCSI’s second major clinical centre in Ireland. The three-story building includes amenities for students and staff, tutorial rooms, a lecture theatre, a mock operating theatre, and a practical…

Read More

David Oliver: Does Darzi’s report move NHS recovery and reform further forward?

Following Labour’s general election victory, Health and Social Care Secretary Wes Streeting announced a diagnostic review of the NHS led by Ara Darzi. The report highlights the NHS’s serious issues, including long waiting times, poor access to care, and declining outcomes. Darzi also criticizes past austerity measures, funding cuts, and organizational disruptions that have contributed…

Read More

Antibody-drug conjugate shows promise in treating ovarian and endometrial cancers

At ESMO 2024, new studies show that immunotherapy can benefit women with early-stage endometrial and cervical cancers. One study found promising results with an antibody drug conjugate targeting a specific protein in ovarian and endometrial cancers. Immunotherapy has improved survival in many cancers, but its efficacy in gynecological cancers varies. Pembrolizumab with chemoradiotherapy improved overall…

Read More

‘Encouraging’ Early Data for mRNA Vaccine in Glioblastoma

In a first-in-human clinical trial, an mRNA-based cancer vaccine for glioblastoma showed promising results by inducing T-cell responses in over three-quarters of patients with an acceptable safety profile. The vaccine was able to generate new immune responses and break through immune tolerance to the tumor. Patients with poor prognosis due to MGMT-unmethylated glioblastoma were included…

Read More

Why Former FDA & Verily Exec Amy Abernethy Is Launching a New Venture

Amy Abernethy believes accelerating clinical evidence generation is crucial for personalized healthcare. She, along with Brad Hirsch, launched Highlander Health, a company focused on supporting clinical evidence generation. Highlander consists of two branches: Highlander Health Partners, an investment arm for middle-market companies, and Highlander Health Institute, a platform providing grants for clinical research. The institute…

Read More

Potential Changes to Pension Caps – Where Are We At?

The expert report commissioned by the Department of Finance on potential increases to the Standard Fund Threshold (SFT) limit has not yet been published. There is speculation that the Threshold may increase after the next election, potentially benefiting those approaching retirement and pension drawdowns. The current €2 million threshold, unchanged since 2014, may no longer…

Read More

DarioHealth integrates Twill cardiometabolic platform and more digital health news

DarioHealth is integrating Twill’s condition-specific communities and peer groups into its cardiometabolic platform, aiming to enhance member engagement and improve health outcomes. Navamedic partners with Alex Therapeutics to provide a digital health app for Parkinson’s treatment management. Mobile Health Consumer launches the GLP-1 Prerequisite Program and GLP-1 Lifestyle Support Program to support healthier lifestyle habits…

Read More

An ESMO Day 1 recap: All eyes on TIGIT

ESMO in 30 Seconds is an online newsletter from the European Society for Medical Oncology’s annual meeting in Barcelona. One of the highlights is the presentation of the GALAXIES Lung-201 study on an anti-TIGIT therapy. Roche received FDA approval for an injectable form of its PD-(L)1 inhibitor Tecentriq. AstraZeneca’s Capitello-290 study did not meet its…

Read More

Successful co-production can help tackle inequalities in maternal health outcomes

The MBRRACE-UK report from October 2023 highlights ongoing disparities in birth outcomes for women from ethnic minorities in the UK. Maternal death risks are significantly higher among black and Asian women compared to white women. Despite calls for individualized care and interventions, women from ethnic minorities feel unheard and excluded from solutions. To address this,…

Read More

New initiative aims to support menopausal workers and reduce employer costs

Menopause is a natural life transition that affects many women in their 40s and 50s. The Menopause Society has launched Making Menopause Work™ to help employers support menopausal employees and reduce healthcare costs related to untreated symptoms. The program includes recommendations based on new scientific consensus and aims to create menopause-responsive workplaces. Menopause symptoms can…

Read More

FDA Okays Subcutaneous Ocrelizumab for MS

The FDA has approved a subcutaneous formulation of ocrelizumab for the treatment of relapsing and primary progressive multiple sclerosis. This new injection can be administered in 10 minutes by a healthcare professional and is the first twice-a-year injection approved for both types of MS. The approval was based on data from a phase 3 trial…

Read More

Best Water Flossers Of 2024 For A Cleaner, Healthier Smile

Discover the superhero of oral care with water flossers, making dental routines fun and easy. Say goodbye to tedious traditional flossing with these gadgets that blast away plaque, food particles, and bad breath, providing satisfying and efficient cleaning. Water flossers are particularly beneficial for those with braces or dental work, offering a modern, hassle-free way…

Read More

Understanding the real-world impact beyond clinical symptoms

Inflammatory bowel disease (IBD) impacts an estimated 40,000 people in Ireland, affecting all genders equally and can be diagnosed at any age. The Gutcast podcast series by Crohn’s Colitis Ireland and Johnson & Johnson provides insights into the real-world impacts of IBD through interviews with patients and healthcare professionals. The series covers topics such as…

Read More

Canary receives patent for neural network-powered speech analysis

Canary Speech, a voice biomarker technology company, received a patent for its paired neural networks for speech analysis. This technology enables precise monitoring of changes in an individual’s voice, improving the accuracy of detecting health conditions. The system processes millions of data elements per minute, allowing for real-time assessment of vocal biomarkers for various diseases….

Read More

The First Year of Georgia’s Medicaid Work Requirement Is Mired in Red Tape

Georgia’s experimental Medicaid expansion program, Pathways, requires participants to work, study, or engage in qualifying activities for 80 hours a month in exchange for health coverage. The program, launched in July 2023, has faced challenges with low enrollment, bureaucratic hurdles, and technical issues. Despite the high cost of administration and consulting fees, the program has…

Read More

Is It Time for Universal Suicide Screening?

US suicide rates have dramatically increased by 37% from 2000 to 2022, resulting in nearly 49,000 deaths in 2022 alone. Calls for universal suicide screening have emerged, but the psychiatric field is divided, citing issues like false positives and lack of resources. Proponents argue that screening can detect at-risk individuals for early intervention. Hospitals like…

Read More
Advertise here
error: Content is protected !!